AISAP Cardio vs HeartFlow Analysis
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if you require rapid, AI-powered cardiac diagnostic assessments directly at the point of care, such as in an emergency department or intensive care unit. This tool is ideal for immediate bedside evaluation of structural heart disease, heart failure, and valvular pathologies, providing quick measurements and interpretations to inform urgent clinical decisions.
View AISAP Cardio →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you need a non-invasive, detailed assessment of coronary artery disease (CAD) severity and its impact on blood flow, derived from standard CT scans. This solution is best suited for risk stratification, guiding treatment strategies, and avoiding unnecessary invasive procedures by providing personalized 3D models, FFRct, and plaque analysis.
View HeartFlow Analysis →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | HeartFlow Analysis |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Cloud-based | Cloud-based (AWS) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for point-of-care ultrasound (POCUS) at the bedside, emphasizing rapid assessments and integration into existing clinical workflows. This focus on immediate, clinician-led use in a dynamic setting suggests a highly intuitive and accessible user experience.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis provides a non-invasive solution for diagnosing and managing coronary artery disease (CAD) through AI-powered 3D models and Fractional Flow Reserve derived from CT (FFRct) analysis. The FFRct analysis offers a functional assessment of coronary lesions, which is a significant advancement in guiding treatment decisions and has high diagnostic accuracy.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis clearly outlines its reimbursement strategy, operating on a fee-for-service model with established Category I CPT codes (75580 and 75577 for 2026) and coverage by Medicare and most U.S. commercial payers. This transparency and established reimbursement pathway significantly enhance its value proposition for healthcare providers.
Enterprise Readiness
HeartFlow AnalysisHeartFlow Analysis explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), which are crucial for handling protected health information in enterprise healthcare environments. While AISAP Cardio likely requires these, their explicit mention by HeartFlow provides greater assurance for large-scale deployment.
Innovation
HeartFlow AnalysisHeartFlow Analysis is highly innovative with its use of AI and Computational Fluid Dynamics (CFD) to create personalized 3D models and derive FFRct from standard CT scans. This non-invasive functional assessment of CAD represents a significant advancement in cardiology, potentially reducing the need for invasive procedures.
Support & Docs
TieNeither the provided structured facts nor readily available public web searches offer specific details regarding the depth, accessibility, or structure of support and documentation for either AISAP Cardio or HeartFlow Analysis. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | HeartFlow Analysis |
|---|---|---|
| Product Name | AISAP Cardio | HeartFlow Analysis |
| Company | Aisap | HeartFlow |
| Primary Focus | AI-powered point-of-care ultrasound (POCUS) software for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | Software and AI designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. |
| Key Diagnostic Method | AI-powered interpretation for point-of-care ultrasound (POCUS) | AI-powered 3D modeling of coronary arteries from CT scans, Fractional Flow Reserve derived from CT (FFRct) analysis, Computational Fluid Dynamics (CFD) |
| Specific Measurements/Outputs | Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Measurement of Left Ventricle Ejection Fraction (LVEF), Measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. Automated generation of analyses, interpretations, and reports. | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading. |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and HeartFlow Analysis.